Orthopediatrics (KIDS) executive reports stock grant and tax-related sale

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP executive Joseph W. Hauser reported a stock grant and related tax sale. He acquired 65,700 shares of Common Stock on March 15, 2026 as a grant at $0.00 per share, increasing his direct holdings to 203,363 shares.

On March 16, 2026, 8,596 shares were sold at $17.25 per share to satisfy tax withholding obligations upon vesting of restricted shares. After these transactions, he directly owned 194,767 shares of Common Stock, including restricted stock awards totaling 155,805 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hauser Joseph W

(Last) (First) (Middle)

6428 RIDGELINE DR

(Street)

HUDSON OH 44236

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres. Trauma & Def. Correction

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		A		65,700	A	$0	203,363	D
Common Stock	03/16/2026		S		8,596(1)	D	$17.25	194,767(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.

2. Includes restricted stock awards totaling 155,805 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did KIDS executive Joseph W. Hauser report?

Joseph W. Hauser reported two transactions in Common Stock. He received a grant of 65,700 shares on March 15, 2026, then 8,596 shares were sold on March 16, 2026 to cover tax withholding obligations tied to restricted share vesting.

How many ORTHOPEDIATRICS (KIDS) shares did Hauser sell and at what price?

Hauser had 8,596 shares of ORTHOPEDIATRICS Common Stock sold at $17.25 per share on March 16, 2026. The footnote explains this sale was to satisfy tax withholding obligations upon vesting of restricted shares, rather than a discretionary open-market sale.

What stock grant did KIDS executive Joseph W. Hauser receive?

Hauser received a grant of 65,700 shares of ORTHOPEDIATRICS Common Stock on March 15, 2026 at $0.00 per share. This grant increased his direct holdings to 203,363 shares immediately after the award, before the subsequent tax-related share sale.

How many ORTHOPEDIATRICS (KIDS) shares does Hauser hold after these transactions?

Following the March 2026 grant and tax-related sale, Hauser directly holds 194,767 ORTHOPEDIATRICS Common Stock shares. This total explicitly includes restricted stock awards amounting to 155,805 shares, according to the footnote describing his post-transaction holdings.

Are Hauser’s ORTHOPEDIATRICS (KIDS) share sales part of regular tax withholding?

Yes. The filing footnote states the 8,596 shares sold on March 16, 2026 were used to satisfy tax withholding obligations triggered by the vesting of restricted shares, indicating the disposition was tied to compensation-related tax requirements.